ReviewFrontiers in pharmacology2022

Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non-Small Cell Lung Cancer.

Dehua Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.